Videos / Protein based COVID-19 vaccine
In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access
(8 mins).

Abnormal Liver Function Test Interpretation

Recurrent Nasal Polyps Management – When to Refer

Breast Density and Cancer Risk – What Every GP Can Put into Practice Tomorrow

Practical Strategies to Address Falling Vaccination Rates in Mums and Bubs

expert
Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland